Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 6:32 PM
Ignite Modification Date: 2025-12-24 @ 6:32 PM
NCT ID: NCT01399957
Eligibility Criteria: Inclusion Criteria: * Confirmed clinical diagnosis of MS by McDonald criteria * Prescribed ampyra (dalfampridine) as part of usual care, but have not yet started taking the medication before baseline visit * Receive MS care at the Mandell MS center * Cognitively able to understand directions and complete protocol (score of 22 or greater on the MMSE) * 18 years of age or older Exclusion Criteria: * Already began to take drug prior to baseline research visit * Not planning to continue care at Mandell Center for at least 14 weeks after initiation of therapy * Unwilling or unable to complete assessments
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT01399957
Study Brief:
Protocol Section: NCT01399957